Amicus Therapeutics, Inc. (FOLD) Stock Analysis
DELISTED 2026
What happened to Amicus Therapeutics, Inc. (FOLD) stock?
Amicus Therapeutics, Inc. (FOLD) no longer trades on public markets. It was delisted in April 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- April 2026
- Last recorded price (historical):
- $14.49 (last quote on record before the April 2026 delisting; historical, not a current quote)
P/E 17.69 means the share price is 17.69 times one year of earnings per share. Market cap $4.55B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Amicus Therapeutics, Inc. (FOLD). Amicus Therapeutics, Inc. is a biotechnology company focused on developing and delivering medicines for rare diseases, with a commercial product, Galafold, for Fabry disease.
Last analyzed: Jun 14, 2026Amicus Therapeutics, Inc. (FOLD) Healthcare & Pipeline Overview
More about this archive record
Can I still buy FOLD shares?
No. FOLD stopped trading on public markets in April 2026, so the shares are not available through a broker. Anything you see quoted for FOLD elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before FOLD stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Amicus Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.